Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00085774 · ClinicalTrials.gov registry record · Phase 3
Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma
A Phase 3 study, sponsored by Teva Branded Pharmaceutical Products R&D.
- Completed
- Registry status
- Phase 3
- Development phase
- 24
- Enrollment target
NCT00085774: Completed Phase 3 study, sponsored by Teva Branded Pharmaceutical Products R&D.
NCT00085774 is a Phase 3 study that has completed, run by Teva Branded Pharmaceutical Products R&D. The registered enrollment target is 24 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00085774, a Phase 3 study, has completed, sponsored by Teva Branded Pharmaceutical Products R&D.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study was designed to examine the effectiveness of two bronchodilator inhalers in patients who have exercise-induced asthma.
Interventions
- DRUG albuterol aerosol by HFA MDI
- DRUG albuterol aerosol by HFA BOI
- DRUG placebo aerosol by HFA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2004-06-30 |
| Est. Completion | 2004-09-30 |
| Phase | Phase 3 |
What the finished NCT00085774 record still lists
NCT00085774 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which albuterol aerosol by HFA MDI is the first listed.
NCT00085774 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00085774 about?
NCT00085774 is a clinical study titled "Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma". This study was designed to examine the effectiveness of two bronchodilator inhalers in patients who have exercise-induced asthma.
What is the current status of trial NCT00085774?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 24 participants. The study started on 2004-06-30. Estimated completion is 2004-09-30.
What interventions are being tested in trial NCT00085774?
The interventions under investigation include: albuterol aerosol by HFA MDI (DRUG), albuterol aerosol by HFA BOI (DRUG), placebo aerosol by HFA (DRUG).
Who is sponsoring clinical trial NCT00085774?
This trial is sponsored by Teva Branded Pharmaceutical Products R&D, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00085774's enrollment target sits among peer trials
24 1943rd of 2000 higher than 49 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI